Tue, Jan 23, 2024
"Our Q3 FY24 numbers reflect our commitment to quality growth, with revenue from operations rising by 5.9 per cent. This was fuelled by the robust performance of the US, LATAM (Latin American), RoW (Rest of the World) and India markets," Glenmark Life Sciences MD & CEO Yasir Rawjee said.
More >
Fri, Oct 20, 2023
Glenmark Life Sciences Q2 Results: Glenmark Life Sciences said its profit after tax rose 11 per cent year-on-year to Rs 119 crore for the second quarter ended September 30, 2023.
Mon, Oct 16, 2023
Glenmark Life Sciences dividend record date 2023: Mumbai-based active pharmaceutical ingredients (API) manufacturer Glenmark Life Sciences earlier announced a dividend of Rs 22.5 per equity share, its first interim dividend for the financial year.
Mon, Oct 09, 2023
Glenmark Life Sciences in its board meeting today (October 9) announced an interim dividend of Rs 22.5 per share.
Thu, Oct 05, 2023
Glenmark Life Sciences board meeting: Glenmark Life Sciences’ board is scheduled to meet next week to consider and approve its quarterly financial results and what could be the company’s first interim dividend for the current financial year.
Fri, Sep 29, 2023
Last seen, shares of Glenmark Pharma traded 5.17 per cent higher at Rs 818.20 apiece. The market capitalisation of the company stood at around Rs 23,127 crore. The stock continued its rally for the third consecutive session.
Mon, Jun 12, 2023
Glenmark Life Sciences share price: The scrip zoomed after reports said that Mumbai-based pharmaceutical company Sekhmet Pharmaventures and Ahmedabad-based Nirma Group are in race to acquire Glenmark Life Sciences.
Fri, Mar 17, 2023
Glenmark Life Sciences dividend news 2023: The stock of Glenmark Life Sciences — a Mumbai-based manufacturer of active pharmaceutical ingredients (APIs) — jumped almost five per cent on Friday, after the company's board declared a dividend of Rs 21 per equity share of face value Rs 2.
Thu, Apr 21, 2022
Tata Elxsi, Glenmark Life Sciences, ICICI Securities came up with their March quarter results on Wednesday.
Mon, Aug 30, 2021
Dr Yasir Rawjee, Managing Director and Chief Executive Officer, Glenmark Life Sciences, talks about listing, Q1FY22 numbers, API business, CDMO business, debt situation and CapEx plan among others during a candid chat with Swati Khandelwal, Zee Business. Edited Excerpts:
Mon, Aug 09, 2021
Glenmark Life Sciences Limited, which made its market debut on 6 August fell on Monday - its second trading day on the go. The stock fell by almost 5% on Monday on the intraday basis taking it to a low of Rs 713.85 before settling at Rs 736.90 at the end of today's trading session.
Fri, Aug 06, 2021
Glenmark Life Sciences is an API subsidiary of Glenmark Pharma, as 40 per cent of its business comes from the parent company.
Fri, Jul 23, 2021
The company will be coming up with initial public offerings to raise funds through fresh issue of equity shares aggregating up to Rs 1,060 crore.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
